AbbVie is a research-based biopharmaceutical company. The company's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. The company also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

AMAG Austria Metall is a holding company, engaged in the production of primary aluminum, as well as cast and rolled aluminum products. The metal division is responsible for the risk management and steering of the metal flows. The casting division recycles aluminum scrap to produce foundry alloys. Its product portfolio covers aluminum materials tailored to customer requirements in the form of ingots, sows and liquid aluminum. The rolling division is responsible for the production and sale of rolled products, and precision cast and rolled plates. The service division include facility management, energy supplies, waste disposal, and purchasing and materials management.

ANGI Homeservices connects homeowners to home service professionals through its portfolio of digital home services brands. The company has two segments: North America (United States and Canada), which includes HomeAdvisor digital marketplace service (HomeAdvisor), Angie's List, its subsidiary, Handy Technologies, Inc. (Handy), mHelpDesk and HomeStars; and Europe, which includes Travaux, MyHammer, My Builder, Werkspot and Instapro. HomeAdvisor provides consumers with tools and resources to help them find local, pre-screened and customer-rated service professionals, as well as book appointments online. Handy connects individuals looking for household services with pre-screened service professionals.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer immunotherapies. The company has four clinical-stage product candidates: AB928, which is an orally bioavailable, reversible antagonist of the adenosine 2a and adenosine 2b receptors; AB680, which is a reversible and selective inhibitor of the CD73 enzyme; AB122, which is a human antibody with similar binding affinity and other characteristics to the marketed anti-PD-1 antibodies pembrolizumab and nivolumab; and AB154, which is a humanized antibody that inhibits an immune checkpoint target involved in a pathway that plays both inhibitory and stimulatory roles in the immune system.

Armada Hoffler Properties is a holding company and conducts substantially all of its operations through Armada Hoffler, L.P. The company is a real estate company engaged in developing, building, owning and managing institutional-grade office, retail and multifamily properties primarily throughout the Mid-Atlantic and Southeastern U.S. In addition to the ownership of its operating property portfolio, the company develops and builds properties for its own account and through joint ventures between the company and unaffiliated partners and also invests in development projects through mezzanine lending arrangements. The company also provides general contracting services to third parties.

ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. The company's clinical pipeline includes: ARQ 531, which is a reversible dual inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; Miransertib, which is a selective inhibitor of protein kinase B (AKT) in combination with the hormonal therapy, anastrozole; ARQ 751, which is a selective inhibitor of AKT for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase and tensin homolog (PTEN) mutations or that are PTEN null; and Derazantinib, which is a multi-kinase inhibitor.

Ashford Hospitality Trust together is an externally-advised real estate investment trust focused on investing in the hospitality industry with a focus predominantly on hotels in the U.S. The company owns its lodging investments and conducts its business through Ashford Hospitality Limited Partnership, its operating partnership. The company is advised by its subsidiary, Ashford Hospitality Advisors LLC (Ashford LLC), through an advisory agreement. All of the hotel properties in the company's portfolio are asset-managed by Ashford LLC. The company's hotel properties are primarily branded under the brands of Hilton, Hyatt, Marriott and Intercontinental Hotels Group.

Associated Capital Group provides alternative investment management services and institutional research services, as well as management of its proprietary investment portfolio. In its alternative asset management operations, subsidiaries of the company serve as general partner or investment manager to investment funds including limited partnerships, offshore companies and separate accounts. The company primarily manages assets in equity event-driven value strategies, across a range of risk and event arbitrage portfolios. Also, the company provides institutional research services through its subsidiary, G.research, LLC, which is a broker-dealer and also acts as an underwriter primarily for the company's affiliates.

Beacon Roofing Supply is a distributor of roofing materials and complementary building products in the United States and Canada. The complementary building products the company distributes include siding, windows, insulation, waterproofing systems, wallboard, acoustical ceilings, and other exterior and interior building products. The company purchases products from manufacturers and then distributes these goods to a customer base consisting of contractors, and to a lesser extent, home builders, retailers, and other building materials suppliers. The company supports its customers with services such as advice and assistance on product identification, specification and technical support, and training services.

Calithera Biosciences is a clinical-stage bio-pharmaceutical company focused on fighting cancer and other life threatening diseases by discovering and developing small molecule drugs that targets cellular metabolism. The company's main product candidate, telaglenastat (CB-839), is a selective glutaminase inhibitor that blocks glutamine consumption in tumor cells and demonstrates synergistic antitumor effects with multiple anticancer therapies.Co.'s other product candidate, INCB001158, is an oral inhibitor of arginase, an enzyme that depletes the amino acid arginine, a key metabolic nutrient for T-cells and it is being co-developed with Incyte Corporation, for oncology and hematology indications.

Capital Senior Living is an operator of senior housing communities. The company provides senior living services, including independent living services, which are provided to seniors who do not yet need assistance, but who prefer the physical and psychological comfort of a residential community that provides health care and other services; assisted living services, which include personal care services, 24-hour staffing, support services, and supplemental services; and memory care services, which maintain programs and living accomodations for residents with certain forms of dementia. The company makes home care services available to clients at its senior housing communities through third-party providers.

Carnival is a leisure travel and cruise company. Co. operates over 100 cruise ships within a portfolio of global, regional and national cruise brands that sell tailored cruise products, services and vacation experiences. Co.'s North America cruise brands include Carnival Cruise Line, Princess Cruises, Holland America Line, and Seabourn. Co. also has a Cruise Support segment that represents its portfolio of port destinations and private islands, which are operated for the benefit of its cruise brands. In addition to its cruise operations, Co. owns Holland America Princess Alaska Tours, the tour company in Alaska and the Canadian Yukon, which complements Co.'s Alaska cruise operations.

CB Financial Services is bank holding company. Through its wholly owned subsidiary, Community Bank (the Bank), the company provides residential and commercial real estate loans, commercial and industrial loans, and consumer loans as well as a variety of deposit products for individuals and businesses in its market area. In addition, the Bank is the sole shareholder of Exchange Underwriters, Inc., a wholly-owned subsidiary that is an independent insurance agency that provides property and casualty, commercial liability, surety and other insurance products.

Central Federal is a bank holding company and financial holding company. Through its wholly owned subsidiary, CFBank, National Association (CFBank), the company provides personalized Business Banking products and services including commercial loans and leases, commercial and residential real estate loans and treasury management depository services. In addition, CFBank provides residential lending and retail banking services and products. CFBank provides a variety of deposit accounts with a range of interest rates and terms including savings accounts, retail and business checking accounts, money market accounts and certificates of deposit.

Compass Diversified Holdings is a statutory trust that acquires and manages a group of small and middle-market businesses. The company's businesses include: branded consumer businesses, which includes its subsidiary, 5.11 ABR Corp., that provides purpose-built tactical apparel and gear for law enforcement, firefighters, EMS, and military special operations as well as outdoor and adventure enthusiasts; and niche industrial businesses, which includes its subsidiary, Foam Fabricators Inc., that designs and manufactures custom molded protective foam solutions and original equipment manufacturer components made from expanded polystyrene and other expanded polymers.

Corvus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. The company develops small molecules that are designed to selectively inhibit the binding of immunosuppressive adenosine to either A2A receptors or to A2B receptors. The company's initial product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine. The company's second clinical product candidate, CPI-006, is an anti-CD73 monoclonal antibody that is designed to both inhibit the production of adenosine and stimulate various immune cells. The company's third clinical product candidate, CPI-818, is a selective, covalent inhibitor of ITK.

Exela Technologies is a provider of transaction processing solutions, enterprise information management, document management and digital business process services. The company has three segments: Information and Transaction Processing, which provides solutions and services designed to aid businesses in information capture, processing, decisioning and distribution; Healthcare Solutions, which operate and maintain a consulting and outsourcing business focusing on both the healthcare provider and payer markets; and Legal and Loss Prevention Services, which provide a line of legal services in connection with class action, bankruptcy labor, claims adjudication and employment and other legal matters.

G-III Apparel Group designs, sources and markets a range of apparel, including outerwear, dresses, sportswear, swimwear, women's suits and women's performance wear, women's handbags, footwear, small leather goods, cold weather accessories and luggage. The company has two segments: wholesale operations, which includes sales of products under brands licensed by the company from third parties and sales of products under its own brands and private label brands, and sales related to the Vilebrequin business; and retail operations, which consists of the company's Wilsons Leather, G.H. Bass and DKNY stores operated as outlet stores, and a limited number of Calvin Klein Performance and Karl Lagerfeld Paris stores.

Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer vaccines. The company uses its platform, AnTigen Lead Acquisition System (ATLAS?), to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company's product candidate, GEN-003, an immunotherapy for the treatment of genital herpes. The company's preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed antigens unique to each patient, that are associated with that individual's tumor.

Greif is a producer of industrial packaging products and services. The company's segments are: Rigid Industrial Packaging and Services, which products including steel, fibre and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, and transit protection products; Paper Packaging and Services, which produces and sells containerboard, corrugated sheets, corrugated containers and other corrugated products; Flexible Products and Services, which produces flexible intermediate bulk containers and related services; and Land Management, which is focused on the harvesting and regeneration of the company's United States timber properties.

Hemispherx Biopharma is a pharmaceutical company. The company is engaged in the development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. The company's primary products include: Alferon N Injection? and the experimental therapeutic Ampligen?. Alferon N Injection? is approved for a category of sexually transmitted disease infection, and Ampligen? represents an experimental RNA being developed for viral diseases and disorders of the immune system. The company's platform technology includes components for potential treatment of various severely debilitating and life threatening diseases.

i3 Verticals is a holding company. Through its subsidiaries, the company provides integrated payment and software solutions to small-and medium-sized businesses and organizations in vertical markets. The company's payment processing services enable clients to accept electronic payments, facilitating the exchange of funds and transaction data between clients, financial institutions and payment networks. The company has two reportable segments: Merchant Services, which provides payment solutions to businesses and organizations; and Proprietary Software and Payments, which provides embedded payment solutions to its clients through company-owned software.

Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. The Company uses therapeutic vaccines to treat an already existing disease and is thus given to the already sick patients; therapeutic cancer vaccines administered to patients in order to delay or stop tumor cell growth, shrink tumors, prevent relapse, or to kill cancer cells that could not be eliminated with other treatments. The Company has several technology platforms, such as The Combig, Intuvax@, Subcuvax@ and The CD70, among others. The Company has several projects which are related to kidney cancer and liver cancer, among others.

LeMaitre Vascular is a provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons. The company's portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and includes the LeMaitre valvulotome, the XenoSure biologic patch, the Pruitt F3 carotid shunt, VascuTape radiopaque tape, and Syntel embolectomy catheters. The company's principal product offerings are sold throughout the world, primarily in the United States, Europe and Asia/Pacific Rim.

Lowe's Companies is a home improvement retailer. The company provides home improvement products in lumber and building materials, appliances, seasonal and outdoor living, tools and hardware, fashion fixtures, rough plumbing and electrical, paint, millwork, lawn and garden, flooring, and kitchens categories. The company provides installation services through independent contractors in product categories, including appliances, flooring, kitchens, lumber and building materials, and millwork. The company also provides extended protection plans for various products within the appliances, kitchens, fashion fixtures, millwork, rough plumbing and electrical, seasonal and outdoor living, and tools and hardware categories.

Mesa Laboratories has four divisions: Sterilization and Disinfection Control, which provides testing services, along with the manufacture and marketing of biological, chemical and cleaning indicators; Instruments, which designs, manufactures and markets quality control instruments and disposable products utilized in the healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries; Cold Chain Monitoring, which designs, develops and markets systems which are used to monitor various environmental parameters; and Cold Chain Packaging, which provides thermal packaging products.

Motus GI Holdings is a development stage company. The company has developed the Pure-Vu system, a medical device. The Pure-Vu System is indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard and slim colonoscopes to enable cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter.

Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The company is developing multiple precision-targeted products based on its Manocept? platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. The company's business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform and NAV4694; and therapeutic development programs, including therapeutic applications of its Manocept platform.

Perceptron develops, produces and sells automated industrial metrology products and solutions to manufacturing organizations for dimensional gauging, dimensional inspection and 3D scanning. The company's In-Line and Near-Line Measurement Solutions are based on a combination of its non-contact Helix? sensor technology and Vector software. The company's Off-Line Measurement Solutions are based on its Coord3? coordinate measuring machines, V7 3D Laser Scanner, plus TouchDMIS? measuring software. The company's 3D Scanning Solutions include its WheelWorks? software and sensors which provide a method of measuring wheel position for use in automated or manual wheel alignment machines in automotive assembly plants.

RiceBran Technologies is an ingredient company serving food, animal nutrition and specialty markets focused on processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry. The company converts raw rice bran into various products including: stabilized rice bran (SRB); RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and its family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Safestore Holdings is engaged in the rental of self-storage space and the sale of ancillary products such as insurance and merchandise (for example, packing materials and padlocks) in both the U.K. and Paris.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. The company's main solar service offerings are provided through its lease and power purchase agreements, which it refers to as its Customer Agreements. While homeowners have the option to purchase a solar energy system outright from the company, a majority of its customers choose to buy solar as a service through its Customer Agreements. With its solar service offerings, the company installs solar energy systems on its customers' homes and provides them the solar power produced by those systems. In addition, the company monitors, maintains and insures the system during the term of the contract.

United Therapeutics is a biotechnology company. The company markets and sells four commercial therapies to treat pulmonary arterial hypertension (PAH): Remodulin? (treprostinil) Injection; Tyvaso? (treprostinil) Inhalation Solution; Orenitram? (treprostinil) Extended-Release Tablets; and Adcirca? (tadalafil) Tablets. The company also markets and sells an oncology product, Unituxin? (dinutuximab) Injection for treatment of high-risk neuroblastoma. The company also engages in research and development of new indications and formulations and delivery devices for its existing products, as well as new products to treat PAH and other conditions. The company also engages in organ transplantation-related technologies.

Vermillion is engaged in the discovery, development and commercialization of diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women. The company concentrates its development of diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer. The company's primary product, OVA1, is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high risk of having a malignant ovarian tumor prior to planned surgery. The company's ASPiRA LABS engages in applying biomarker-based technologies to address needs in the management of gynecologic cancers and disease.

VSE is a services and supply chain management company. The company's segments are: Supply Chain Management Group, which provides sourcing, acquisition, scheduling, transportation, shipping, logistics, data management, and other services; Aviation Group, which provides parts supply and distribution, supply chain solutions, and maintenance, repair, and overhaul services; and Federal Services Group, which provides foreign military sales services, refurbishment services, fleet-wide ship and aircraft support, aircraft sustainment and maintenance, and other technical, management, engineering, logistics, maintenance, configuration management, prototyping, technology, and field support services.

Washington Prime Group operates as a self-administered and self-managed real estate investment trust. Washington Prime Group, L.P. (WPG L.P.) is the company's majority-owned limited partnership subsidiary that owns, develops, and manages, through its affiliates, all of the company's real estate properties and other assets. The company is the sole general partner of WPG L.P. The company owns, develops and manages enclosed retail properties and open air properties. The company's assets consist of material interests in shopping centers in the United States.